Cagrilintide: The Next Big Thing in Fat Loss or Just Hype? : r BoldReseachPeptides Targeting the incretin system in obesity and type 2 diabetes mellitus Nature Reviews Endocrinology Characterization of 0839 A tool compound for pre clinical mode of action studies of amylin analogues such as cagrilintide ScienceDirect Cagrilintide Wikipedia Cagrilintide is a long acting amylin analog that regulates appetite, gastric emptying, and glucagon secretion to treat obesity and related metabolic disorders. There are 2 pathways cagrilintide works: Cagrilintide (10mg vials) Peptide Partners